---
$id: https://graph.org.ai/products/commodity/51281653
$type: Product
source: UNSPSC
code: "51281653"
title: "Kanamycin a"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Kanamycin a

**UNSPSC Code**: 51281653
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H36N4O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EQK9Q303C5, chemically known as d-streptamine, o-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as kanamycin a, which bears US NIH Compound Identifier 6032. European Medicines Agency schedules kanamycin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08362MIG. Most nations, for tariff purposes, schedule kanamycin a under HS 29419000. Kanamycin a bears US NLM identifiers UMLS ID C0022489 and NCI Concept Code C76151. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N.

